CB7630
Showing 1 - 25 of 41
Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Sunitinib)
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 6, 2022
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Abiraterone Acetate,
Active, not recruiting
- Metastatic Prostate Carcinoma
- +2 more
- Abiraterone Acetate
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Feb 23, 2022
Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone
Active, not recruiting
- Metastatic Prostate Carcinoma
- +5 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 26, 2022
Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Abiraterone Acetate, Sodium Selenite, Prednisone)
Withdrawn
- Prostate Cancer
- Castrate Resistant Prostate Cancer
- Abiraterone Acetate
- +2 more
- (no location specified)
Aug 5, 2021
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Without Neuroendocrine Differentiation, Stage IV Prostate
Suspended
- Castration-Resistant Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 27, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,
Completed
- Prostate Adenocarcinoma
- +4 more
- Abiraterone Acetate
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,
Recruiting
- Prostate Carcinoma
- +6 more
- Abiraterone Acetate
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in
Completed
- Stage III Prostate Adenocarcinoma AJCC v7
- +3 more
- Abiraterone Acetate
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 15, 2021
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Seattle (Abiraterone
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Abiraterone Acetate
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Apr 22, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone Acetate
- +6 more
-
Houston, Texas
- +2 more
Feb 11, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer Trial in Salt Lake City
Terminated
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +5 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Jun 5, 2020
Castration-Resistant Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in United States
Completed
- Castration-Resistant Prostate Carcinoma
- +2 more
- Abiraterone Acetate
- +3 more
-
Duarte, California
- +13 more
Oct 21, 2020
Castration-resistant Prostate Cancer, Stage IV Prostate Cancer Trial in Singapore, United States (abiraterone acetate)
Completed
- Castration-resistant Prostate Cancer
- Stage IV Prostate Cancer
- abiraterone acetate
-
Atlanta, Georgia
- +5 more
Jul 2, 2019
Prostatic Tumors Trial in Worldwide (Pembrolizumab, Olaparib, Abiraterone acetate)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +4 more
-
Fullerton, California
- +192 more
Oct 17, 2022
Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)
Completed
- Prostate Cancer
- Abiraterone acetate
- +2 more
-
Chicago, Illinois
- +15 more
Oct 25, 2021
Castrate-resistant Prostate Cancer Trial in San Francisco (BEZ235, Prednisone, Abiraterone acetate)
Terminated
- Castrate-resistant Prostate Cancer
- BEZ235
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 27, 2018
Breast Cancer at Brazilian Institutions - Project AMAZONA III
Completed
- Breast Cancer
-
Salvador, Bahia, Brazil
- +23 more
Jun 14, 2021
Prostate Cancer Trial in San Francisco, Chicago (Abiraterone acetate)
Completed
- Prostate Cancer
- Abiraterone acetate
-
San Francisco, California
- +1 more
Dec 6, 2017
Prostate Cancer Trial in Boston, Seattle (Abiraterone acetate, Dutasteride, Prednisone)
Completed
- Prostate Cancer
- Abiraterone acetate
- +2 more
-
Boston, Massachusetts
- +3 more
Feb 16, 2018
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue
Recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone Acetate
- +6 more
-
Fairbanks, Alaska
- +671 more
Dec 29, 2021
Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Los Angeles (abiraterone
Unknown status
- Hormone-resistant Prostate Cancer
- +2 more
- abiraterone acetate
- +2 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Jul 5, 2017